摘要
制备了呋喃唑酮胃内滞留漂浮型缓释片剂(简称 Fu-HBS)。它以零级及 Higuchi 方式在体外释药。γ-闪烁照相结果表明,Fu-HBs 在人胃内滞留时间为4~6h,明显长于普通片(1~2h)。实验表明,Fu-HBS 片稳定,贮存期暂定两年。初步试验表明,其对幽门弯曲菌清除率为70.0%,胃窦粘膜病理炎症的好转率为75.0%。
Furazolidone floating sustained-release tablet(Fu-HBS)was pre-pared.The drug was released in vitro according to zero-order kinetics and Higu-chi equation simultaneously.γ-Scintiphotography showed the residence time inthe stomach of Fu-HBS was 4~6h,which was much longer than that furazolidoneconventional tablets(1~2h).The effects of temperature and humidity on thestability of Fu-HBS were studied.The effect of Fu-HBS on Campylobacter pylori(CP)was examined through clinical trial.Negative rate of CP and improvementrate of inflammation in the gastric mucosa were 70.0%,75.0% respectively.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
1992年第1期10-12,共3页
Chinese Journal of Pharmaceuticals
关键词
漂浮型缓释片
幽门弯曲菌
呋喃唑酮
furazolidone
floating sustained-release tablet
dissolution
Campylobacter pylori
treatment